TY - JOUR
T1 - Laparoscopic management of peptic ulcer disease
AU - Casas, A. T.
AU - Gadacz, T. R.
N1 - Copyright:
Copyright 2018 Elsevier B.V., All rights reserved.
PY - 1996
Y1 - 1996
N2 - Laparoscopic surgery has heralded a new era for the operative management of peptic ulcer disease. With a mean hospital stay of 3.5 days, a recurrence rate of 4% to 11%, and a morbidity from dumping and diarrhea of 1% to 2%, laparoscopic proximal gastric vagotomy can truly provide a good alternative to medical therapy. Despite the high cost of medical care and surgical equipment, a laparoscopic vagotomy should be cost effective compared with life-long pharmacologic management of peptic ulcer disease. Several different operative procedures have been discussed, with similar outcomes. The surgeon has a choice of several approaches, depending on his or her training and level of skill. As surgeons gain experience with laparoscopic surgery, we are able to offer consistently good results with low recurrence rates and negligible morbidity and mortality. Minimally invasive surgery has rekindled the operative treatment of peptic ulcer disease.
AB - Laparoscopic surgery has heralded a new era for the operative management of peptic ulcer disease. With a mean hospital stay of 3.5 days, a recurrence rate of 4% to 11%, and a morbidity from dumping and diarrhea of 1% to 2%, laparoscopic proximal gastric vagotomy can truly provide a good alternative to medical therapy. Despite the high cost of medical care and surgical equipment, a laparoscopic vagotomy should be cost effective compared with life-long pharmacologic management of peptic ulcer disease. Several different operative procedures have been discussed, with similar outcomes. The surgeon has a choice of several approaches, depending on his or her training and level of skill. As surgeons gain experience with laparoscopic surgery, we are able to offer consistently good results with low recurrence rates and negligible morbidity and mortality. Minimally invasive surgery has rekindled the operative treatment of peptic ulcer disease.
UR - http://www.scopus.com/inward/record.url?scp=0029897155&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0029897155&partnerID=8YFLogxK
U2 - 10.1016/S0039-6109(05)70458-8
DO - 10.1016/S0039-6109(05)70458-8
M3 - Article
C2 - 8669011
AN - SCOPUS:0029897155
SN - 0039-6109
VL - 76
SP - 515
EP - 522
JO - Surgical Clinics of North America
JF - Surgical Clinics of North America
IS - 3
ER -